Ryan Nelson

6.2k citations
9 papers · 4.7k · 1 hit paper · h-index 6

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Cells and Metastasis
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 3
    • Cancer Treatment and Pharmacology 1

Ryan Nelson

9 papers receiving 4.6k citations

Ryan Nelson's Hit Papers

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. 1997 · 4.6k citations
4.6k0+9+19Years since publication10002.0k3.0k4.0k

Peers

Ryan Nelson
Comparison fields: 5 of 111
  • Oncology 3.9k
  • Cancer Research 1.4k
  • Pulmonary and Respiratory Medicine 1.1k
  • Epidemiology 1.1k
  • Hepatology 202
Replace Connie Stephens with:
Connie Stephens United States
Denis Péré-Vergé France
Faiza Khemissa-Akouz France
Stefan Boeck Germany
M. Christine Cripps Canada
P. Murawa Poland
Andrew H. Ko United States
C. Montoto-Grillot France
David Walde Canada
H. Au Canada
Ryan Nelson relative to Connie Stephens United States Connie Stephens's profile →
Citations per field
00.5×1.5×
Connie Stephens · 1×
Citations per year

Countries citing papers authored by Ryan Nelson

Since Specialization
Citations

This map shows the geographic impact of Ryan Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Nelson more than expected).

Fields of papers citing papers by Ryan Nelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Nelson. The network helps show where Ryan Nelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan Nelson Line = papers co-authored together Ryan Nelson links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Hit paper breakdown →
19974630
2 201131
3 202316
4 202311
5 201111
6 20237
7 20202
8 20151
9 20211

About Ryan Nelson

Ryan Nelson is a scholar working on Oncology, Surgery, Molecular Biology, Economics and Econometrics and Infectious Diseases, having authored 9 papers that have together received 4.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), RNA Interference and Gene Delivery (2 papers), Cancer Treatment and Pharmacology (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Bone health and osteoporosis research (1 paper), HIV-related health complications and treatments (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations), Epidemiology (1.1k citations) and Hepatology (202 citations). Ryan Nelson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Manuel Modiano, Anna Maria Storniolo, Malcolm J. Moore, F. Andrew Dorr, Peter G. Tarassoff, John Sahl Andersen, Daniel D. Von Hoff, Howard A. Burris, Russell K. Portenoy and M. Christine Cripps. Their work appears in journals such as Journal of Clinical Oncology, Value in Health, Pharmaceutics, Oncogene and Heart.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact